Abstract
Introduction

40
The revolution in sequencing capacity has created an unprecedented ability to glimpse into the 41 functionality of microbial communities, using large-scale shotgun metagenomic techniques 42 (Quince et al. 2017 ). This has yielded important insights into broad functional patterns of 43 microbial consortia (Yooseph et al. 2007 ; Human Microbiome Project Consortium 2012; 44 Sunagawa et al. 2015) . However, while overall pathway abundances inferred from metagenomic 45 data can tell us much about the general functions of communities and how they change with e.g. 46 environmental gradients (Bengtsson-Palme 2018; Bahram et al. 2018) , there are many important 47 functional differences that are hidden in the subtleties of these communities (Österlund et al. 48 2017). For example, many antibiotic resistance phenotypes are the results of single point 49 mutations rather than acquisition of novel pathways or genes (Johnning et al. 2013 ). This 50 complicates the studies of selection pressures in environmental communities, as analysis of such 51 mutations is generally limited to a narrow range of species (Johnning et al. 2015b ; Johnning et al. 52
2015a; Kraupner et al. 2018) . 53
Because of the immense increase in available sequence data, it would be desirable to study these 54 mutations from shotgun metagenomic libraries, much as other traits have been studied at a large 55 scale (Pal et al. 2016 ). However, attempts to quantify point mutations in metagenomic sequencing 56 data often go wrong because the methods do not sufficiently well distinguish between mutated 57 and wildtype variants of the same gene. For example, a sequenced read may map to a region 58 identical in the mutated and wildtype variant of a gene, causing problems for quantifying their 59 relative proportions (Bengtsson-Palme et al. 2017 ). In addition, because the sought-after 60 mutations generally are rare in most types of sample, and metagenomic studies are often under-61 sampled in terms of replicates (Jonsson et al. 2016a ), commonly applied statistics methods may 62 not be sufficiently sensitive to reliably detect differences between samples (Jonsson et al. 2016b) . 63
In this study, we attempt to provide a partial remedy to these problems through the introduction 64 of a software tool -Mumame -that can quantify and distinguish between wildtype and mutated 65 gene variants in metagenomic data, and through suggesting a statistical framework for handling 66 the output data of the software. We further demonstrate the ability of the method to detect 67 relevant differences between environmental sample types, estimate the sequencing depths 68 required for the method to perform reliably through simulations, and exemplify the utility of the 69 software on detecting resistance mutations in publicly available metagenomes. 
Methods
73
Software implementation 74
Mumame is implemented in Perl and consists of two commands: mumame, which performs 75 mapping to database of mutations, and mumame_build with builds the database for the former 76 command. The mumame_build command takes a FASTA sequence file and a list of mutations 77 (CSV format) as input. For each entry in the mutation list, it finds the corresponding sequence(s) 78 in the FASTA file, either by sequence identifier or by CARD ARO accessions (Jia et al. 2016 ). It 79 then excerpts a number of residues upstream and downstream of the mutation position (by 80 default 20 residues for proteins and 55 for nucleotide sequences) and creates one wildtype 81 version and one mutated version of the sequence excerpt with unique sequence IDs. For cases 82 where multiple mutations can occur close to each other on the same sequence, the software 83 attempts to create all possible combinations of mutations (if memory permits -is some situations 84 this is not possible because the number of combinations increase exponentially). The software 85 tool also generates a mapping file between sequence IDs in the database and mutation 86 information from the list. 87
The main mumame command takes any number of input files containing DNA sequence reads 88 in FASTA or FASTQ format and maps those against the Mumame database using Usearch 89 (Edgar 2010) . For this mapping, the software runs Usearch in search_global mode with target 90 coverage set to 0.55 (by default; any value ≥ 0.51 should be feasible for target coverage). The 91 output is then mapped to the wildtype or mutation information in the Mumame database, and 92 data is collected for each input file and combined into one single output table. 
Quantification of mutations in metagenomes 102
To quantify the abundances of fluoroquinolone resistance mutations in the gyrA and parC genes 103 (Johnning et al. 2015b ), we downloaded the CARD database on 2018-05-24 (Jia et al. 2016 ). Weextracted all mutation information regarding the gyrA and parC genes from the "snps.txt" file and 105 created a new file with that information. We then created a new Mumame database, with the 106 following command: "mumame_build -i card-data/protein_fasta_protein_variant_model.fasta -m 107 gyrA_parC_snps.txt -o gyrA_parC". That database was used to map all the reads from the 108 samples generated by Kraupner et al. (2018) to the database using Mumame in the Usearch mode 109 (Edgar 2010 ) and the following options "-d gyrA_parC -c 0.95". We did this both for the 110 shotgun metagenomics data as well as for the amplicon sequences derived specifically from 111
Enterobacteriaceae gyrA and parC genes. Prior to this sequence mapping raw reads were quality 112 the reads from the downsampled libraries were mapped to the fluoroquinolone resistance 133 mutation database using Mumame as above. Statistical differences were assessed at all simulated 134 sequencing depths and average effect sizes calculated for the significantly altered genes. 135
Results
136
Mumame can quantify point mutation frequencies in metagenomic data 137
As a proof-of-concept that our method to identify point mutations in metagenomic sequence 138 data is functional, we used Mumame to quantify the mutations in amplicon data from the the 139 gyrA and parC genes. These genes are targets of fluoroquinolone antibiotics, and often acquire 140 resistance mutations attaining high levels of resistance. We quantified such mutations in an 141 amplicon data set specifically targeting these two genes in Escherichia coli. This data set derives 142 from an exposure study with increasing ciprofloxacin concentrations, and enrichments of 143 mutations in the classical fluoroquinolone resistance determining positions S83 and D87 (gyrA) 144 and S80 and E84 (parC) have previously been verified using other bioinformatic methods 145 (Kraupner et al. 2018 ). This data set therefore serves as an ideal positive control for our novel 146 method. We found that Mumame were able to identify the difference between the highest 
164
We next evaluated the performance of Mumame on the real shotgun data that was also generated 165 from the same samples as the amplicon libraries. Ideally, this analysis should generate virtually the 166 same result as the amplicon analysis. Indeed, we found similar results for the A67 and S83 gyrA 167 mutations ( Figure 1B ). For the D87 mutation, the frequencies were much lower than for the 168 other two mutations, albeit still significantly larger than at the lower concentrations (p < 0.01). 169 For the parC gene, the shotgun metagenomic analysis was too noisy to generate a statistically 170 significant result, which was highly surprising to us ( Figure 1D ). Taken together, these results 171 indicate the high noise levels present for individual gene variants even in deeply sequenced 172 shotgun metagenomes from controlled exposure studies. 173
The limits to quantification 174
Noting the much more instable levels of mutations in the shotgun metagenomes, we next 175 investigated the effects of sequencing depth on the ability of our method to detect significantly 176 altered mutation frequencies. For this analysis, we used downsampled data from the shotgun 177 metagenomic library of the ciprofloxacin exposure study (Figure 2 ). As expected, we found that 178 the number of significantly altered mutation frequencies detected increased with larger 179 sequencing depth (Figure 2A ). In addition, the average effect size of the significant mutations 180 became gradually lower with larger sequence depth, also in accordance with expectations ( Figure  181 2B). Importantly, the average effect size of detectable mutation frequency differences seems to 182 decrease linearly with sequencing depth. This means that we can calculate an expected detection 183 limit for the method given the characteristics of the data and experimental setup. At 10 million 184 reads, we expect that the proportion of reads with mutation must be 30-40% higher in the 185 exposed sample in order for it to be detected as significant. The required effect decreases to, on 186 average, 10% higher at 50 million reads ( Figure 2B ). These numbers are of course also dependent 187 on other factors, such as the number of replicates per treatment, but nevertheless they can be 188 not yet at that point in terms of bioinformatic methods and the sequencing depth required to 244 draw firm conclusions. That said, we show in this work that identifying significant and relevant 245 differences in resistance mutation frequencies between sample groups from shotgun 246 metagenomic data is possible, given a sufficiently large sequence depth. However, the 247 quantitative estimates still seem to be highly variable, even at very large sequencing depths. 248
The results of the Mumame evaluation also provides a few other important clues on potential 249 pitfalls with inferring mutation frequencies from shotgun metagenomic data. An important such 250 aspect is the disparity between mutation frequencies described by amplicon sequencing and 251 shotgun data. Particularly, the ability to relatively consistently identify the A67 and S83 mutations 252 in parC, while the D87 mutation is seemingly less frequent in the shotgun data is somewhat 253 troubling if the goal is to identify the actual abundances of such mutations. At the same time, the 254 statistical significance of those differences could still be identified. For the A67 and S83 255 mutations, only 5 million reads were required for a significant effect to be detected, while for the 256 D87 mutations a sequencing depth of 50 million reads was required. This is not necessarily a 257 shortcoming of the Mumame software, but may just as well be due to the much noisier nature of 258 counts from metagenomic sequence data compared to the large number of reads corresponding 259 to the same genes deriving from amplicon data (Jonsson et al. 2016a) . 260
Another important potential problem highlighted by our evaluation is the need to produce very 261 large sequence data sets to be able to identify and quantify mutations (and wildtype) sequences 262 with any certainty. As a rule of thumb, the targeted regions represent less than 0.004% of the 263 bacterial genome, and each bacterial strain may correspond to only a fraction of a percent of the 264 reads in the shotgun sequence data (depending on its abundance). This means that to identify a 265 single read from a resistance region in the data, one would -on average -need to sequence more 266 than five million reads. To get a reasonably confident measure of reads stemming from wildtype 267 versus strains with mutations, approximately 10 reads from each group would be needed per 268 sample (or, say, 20 reads in total). That would, as a rough estimate, correspond to a hundred 269 million reads per sample. This is, unfortunately, way more sequences than what is typically 270 generated per sample by shotgun metagenomic sequencing projects. In this study, only the 271 samples from the tetracycline exposure study corresponded to such a high sequencing depth. 272 Naturally, these numbers would depend on the proportions of the targeted microorganisms as 273 well as their genome sizes, but ultimately this still presents the largest limitation to mutation 274 studies based on metagenomic sequence data. Potentially, this problem could be partially 275 alleviated by analyzing sufficiently large cohorts and perform the statistical analysis for general 276 trends, but even large cohorts would be insufficient for mutations rare enough to pass below the 277 detection limit. 278
In terms of interpreting the results from the exposure experiments, it is interesting to note the 279 overall clear increase of fluoroquinolone resistance mutations at the highest ciprofloxacinconcentration, which nearly perfectly correspond to increases in mobile qnr fluoroquinolone 281 genes in the same samples (Kraupner et al. 2018 ). This is contrasted by the trend seen in the 282 tetracycline exposure experiments, where tetracycline resistance genes -specifically efflux pumps 283 -were enriched at higher tetracycline concentrations (Lundström et al. 2016 ), while tetracycline 284 resistance mutation abundances were not significantly altered. This non-significant result was 285 obtained despite the exceptionally high sequencing depth of those samples. 286
While we did not have data from a proper experimental setup to address differences between 287 sediments exposed to different degrees of fluoroquinolone pollution, the quantification of 288 resistance mutations seems to provide an important piece of information to explain the results of 289 previous studies of resistance gene abundances in these river samples (Kristiansson et al. 2011) . 290
In the original paper, the abundance of mobile fluoroquinolone resistance genes (qnr genes) were 291
shown to be enriched in the low-level polluted upstream samples, compared to the highly 292 polluted downstream samples. Importantly, the qnr genes only provide resistance to relatively low 293 levels of fluoroquinolones (Hooper and Jacoby 2015) , and the authors of hypothesize that 294 chromosomal mutations of the target genes are probably necessary to survive the selection 295 pressure from antibiotics downstream of the pollution source. In this work, we show that this 296 assumption is likely correct. Only a limited number of reads were mapping to these resistance 297 regions and the number of samples unfortunately prevents us from properly assessing a statistical 298 difference between the upstream and downstream samples. Still, the proportion of resistance 299 mutations seems to be systematically higher in the samples downstream of the pollution source, 300 at least for E. coli. This indicates that the method we present here can provide important 301 additional information to metagenomic studies of resistance patterns in different environment 302 types, given that a sufficient sequencing depth is achieved. 303
We have here shown the utility of the Mumame tool for finding resistance mutations in shotgun 304 metagenomic data. In this paper, we have used the CARD database (Jia et al. 2016 ) as the 305 information source for resistance mutation, but the tool is flexible to use any source of such data. 306
It is also not in any means restricted to the mutations investigated in this paper but is 307 fundamentally agnostic to the input data. It can also be used in open screening for mutations in 308 any gene present in the database in parallel, and can handle different mutations in both RNA and 309 protein coding genes. The tool is flexible and fast and can therefore be implemented as a part 310 nearly any screening pipeline for antibiotic resistance data in metagenomic data sets. 311 between wildtype and mutated gene variants in metagenomic data and quantify them, given a 315 sufficient sequencing depth. We also provide a statistical framework for handling the generated 316 count data and account for factors such as differences in sequencing depth. Importantly, our 317 study also reveals the importance of a high sequencing depth -preferably more than 50 million 318 sequenced reads per sample -in order to get reasonably accurate estimates of mutation 319 frequencies, particularly for rare genes or species. The Mumame software package is freely 320 available from http://microbiology.se/software/mumame. We expect Mumame to be a useful 321 addition to metagenomic studies of e.g. antibiotic resistance, and to increase the detail by which 322 metagenomes can be screened for phenotypically important differences. 323 324
Conclusion
